This Multiplex PCR Assays market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The multiplex PCR assays market size has grown rapidly in recent years. It will grow from $1.33 billion in 2023 to $1.51 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth observed in the historic period can be attributed to several factors such as the increased prevalence of infectious diseases, heightened government funding and support, greater adoption in clinical diagnostics, a surge in genetic testing and personalized medicine, expanded use in academic and research institutions, advancements in bioinformatics and data analysis tools, and rising healthcare expenditure.
The multiplex PCR assays market size is expected to see rapid growth in the next few years. It will grow to $2.5 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The projected growth during the forecast period can be attributed to several factors such as the expansion of application areas, rising demand for point-of-care diagnostics, growth in personalized medicine, increased research and development expenditures, heightened health awareness and preventive healthcare, a growing focus on precision medicine, and a rising demand for rapid and reliable diagnostic tests. Major trends expected to drive growth include the integration of next-generation sequencing (NGS), advancements in companion diagnostics, development of digital PCR technology, automation and high-throughput systems, point-of-care and portable devices, enhanced customization and multiplexing capabilities, the application of artificial intelligence and machine learning, improved data management, and cloud-based solutions.
The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.
Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.
In July 2021, DiaSorin SpA, an Italy-based provider of in vitro diagnostic (IVD) products and life science solutions, acquired Luminex Corporation for $1.8 billion. This acquisition aims to strengthen DiaSorin’s diagnostic and life science capabilities by integrating Luminex's multiplexing technology, enhancing its presence in the U.S., and driving growth through advanced solutions and increased engagement with key sectors. Luminex Corporation, headquartered in the U.S., specializes in multiplexing technology and offers a range of applications within the life science industry.
Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation.
North America was the largest region in the multiplex PCR assays market in 2023. The regions covered in the multiplex pcr assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.
The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.
The multiplex PCR assays market research report is one of a series of new reports that provides multiplex PCR assays market statistics, including multiplex PCR assays industry global market size, regional shares, competitors with an multiplex PCR assays market share, detailed multiplex PCR assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex PCR assays industry. This multiplex PCR assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The multiplex PCR assays market size has grown rapidly in recent years. It will grow from $1.33 billion in 2023 to $1.51 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth observed in the historic period can be attributed to several factors such as the increased prevalence of infectious diseases, heightened government funding and support, greater adoption in clinical diagnostics, a surge in genetic testing and personalized medicine, expanded use in academic and research institutions, advancements in bioinformatics and data analysis tools, and rising healthcare expenditure.
The multiplex PCR assays market size is expected to see rapid growth in the next few years. It will grow to $2.5 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The projected growth during the forecast period can be attributed to several factors such as the expansion of application areas, rising demand for point-of-care diagnostics, growth in personalized medicine, increased research and development expenditures, heightened health awareness and preventive healthcare, a growing focus on precision medicine, and a rising demand for rapid and reliable diagnostic tests. Major trends expected to drive growth include the integration of next-generation sequencing (NGS), advancements in companion diagnostics, development of digital PCR technology, automation and high-throughput systems, point-of-care and portable devices, enhanced customization and multiplexing capabilities, the application of artificial intelligence and machine learning, improved data management, and cloud-based solutions.
The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.
Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.
In July 2021, DiaSorin SpA, an Italy-based provider of in vitro diagnostic (IVD) products and life science solutions, acquired Luminex Corporation for $1.8 billion. This acquisition aims to strengthen DiaSorin’s diagnostic and life science capabilities by integrating Luminex's multiplexing technology, enhancing its presence in the U.S., and driving growth through advanced solutions and increased engagement with key sectors. Luminex Corporation, headquartered in the U.S., specializes in multiplexing technology and offers a range of applications within the life science industry.
Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, Quanterix Corporation, NanoString Technologies, Standard BioTools Inc, Enzo Biochem Inc, SeraCare Life Sciences Inc, Agena Bioscience, Fluidigm Corporation.
North America was the largest region in the multiplex PCR assays market in 2023. The regions covered in the multiplex pcr assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.
The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.
The multiplex PCR assays market research report is one of a series of new reports that provides multiplex PCR assays market statistics, including multiplex PCR assays industry global market size, regional shares, competitors with an multiplex PCR assays market share, detailed multiplex PCR assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex PCR assays industry. This multiplex PCR assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Multiplex PCR Assays Market Characteristics3. Multiplex PCR Assays Market Trends and Strategies32. Global Multiplex PCR Assays Market Competitive Benchmarking33. Global Multiplex PCR Assays Market Competitive Dashboard34. Key Mergers and Acquisitions in the Multiplex PCR Assays Market
4. Multiplex PCR Assays Market - Macro Economic Scenario
5. Global Multiplex PCR Assays Market Size and Growth
6. Multiplex PCR Assays Market Segmentation
7. Multiplex PCR Assays Market Regional and Country Analysis
8. Asia-Pacific Multiplex PCR Assays Market
9. China Multiplex PCR Assays Market
10. India Multiplex PCR Assays Market
11. Japan Multiplex PCR Assays Market
12. Australia Multiplex PCR Assays Market
13. Indonesia Multiplex PCR Assays Market
14. South Korea Multiplex PCR Assays Market
15. Western Europe Multiplex PCR Assays Market
16. UK Multiplex PCR Assays Market
17. Germany Multiplex PCR Assays Market
18. France Multiplex PCR Assays Market
19. Italy Multiplex PCR Assays Market
20. Spain Multiplex PCR Assays Market
21. Eastern Europe Multiplex PCR Assays Market
22. Russia Multiplex PCR Assays Market
23. North America Multiplex PCR Assays Market
24. USA Multiplex PCR Assays Market
25. Canada Multiplex PCR Assays Market
26. South America Multiplex PCR Assays Market
27. Brazil Multiplex PCR Assays Market
28. Middle East Multiplex PCR Assays Market
29. Africa Multiplex PCR Assays Market
30. Multiplex PCR Assays Market Competitive Landscape and Company Profiles
31. Multiplex PCR Assays Market Other Major and Innovative Companies
35. Multiplex PCR Assays Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Multiplex PCR Assays Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on multiplex PCR assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for multiplex PCR assays? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiplex PCR assays market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Assay Type: Planar Assay; Bead Based Assay2) By Product And Services: Consumables; Instruments; Software And Services
3) By Application: Disease Diagnosis; Research And Development; Other Applications
4) By End User: Biopharmaceutical Companies; Clinical Research Organizations; Academic Research Institutes; Diagnostic Centers; Other End Users
Key Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Merck KGaA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies profiled in this Multiplex PCR Assays market report include:- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- Danaher Corporation
- Merck KGaA
- Siemens Healthineers
- Becton Dickinson and Company
- Agilent Technologies Inc
- PerkinElmer Inc
- Illumina Inc
- Sysmex Corporation
- Bio-Rad Laboratories Inc
- QIAGEN NV
- Tecan Group Ltd
- DiaSorin SpA
- Bio-Techne Corporation
- Promega Corporation
- Randox Laboratories Ltd
- BioFire Diagnostics Inc
- Seegene Inc
- Quanterix Corporation
- NanoString Technologies
- Standard BioTools Inc
- Enzo Biochem Inc
- SeraCare Life Sciences Inc
- Agena Bioscience
- Fluidigm Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | November 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 1.51 Billion |
| Forecasted Market Value ( USD | $ 2.5 Billion |
| Compound Annual Growth Rate | 13.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
![Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User - Global Forecast to 2030 - Product Image](http://www.researchandmarkets.com/product_images/12541/12541970_60px_jpg/multiplex_assays_market.jpg)
